Dept. of Anatomy and Cell Biology, Faculty of Medicine, Université de Sherbrooke, 3001- 12 Ave. North, Sherbrooke, Quebec, Canada J1H 5N4.
Am J Physiol Regul Integr Comp Physiol. 2011 Feb;300(2):R251-63. doi: 10.1152/ajpregu.00736.2009. Epub 2010 Nov 17.
Plasma membrane endothelin type A (ET(A)) receptors are internalized and recycled to the plasma membrane, whereas endothelin type B (ET(B)) receptors undergo degradation and subsequent nuclear translocation. Recent studies show that G protein-coupled receptors (GPCRs) and ion transporters are also present and functional at the nuclear membranes of many cell types. Similarly to other GPCRs, ET(A) and ET(B) are present at both the plasma and nuclear membranes of several cardiovascular cell types, including human cardiac, vascular smooth muscle, endocardial endothelial, and vascular endothelial cells. The distribution and density of ET(A)Rs in the cytosol (including the cell membrane) and the nucleus (including the nuclear membranes) differ between these cell types. However, the localization and density of ET-1 and ET(B) receptors are similar in these cell types. The extracellular ET-1-induced increase in cytosolic (Ca) and nuclear (Ca) free Ca(2+) is associated with an increase of cytosolic and nuclear reactive oxygen species. The extracellular ET-1-induced increase of Ca and Ca as well as intracellular ET-1-induced increase of Ca are cell-type dependent. The type of ET-1 receptor mediating the extracellular ET-1-induced increase of Ca and Ca depends on the cell type. However, the cytosolic ET-1-induced increase of Ca does not depend on cell type. In conclusion, nuclear membranes' ET-1 receptors may play an important role in overall ET-1 action. These nuclear membrane ET-1 receptors could be targets for a new generation of antagonists.
质膜内皮素 A (ET(A)) 受体被内化并循环回到质膜,而内皮素 B (ET(B)) 受体则发生降解并随后向核内易位。最近的研究表明,G 蛋白偶联受体 (GPCR) 和离子转运体也存在于许多细胞类型的核膜上并具有功能。与其他 GPCR 一样,ET(A) 和 ET(B) 存在于几种心血管细胞类型的质膜和核膜上,包括人心肌、血管平滑肌、心内膜内皮和血管内皮细胞。ET(A)Rs 在细胞质(包括细胞膜)和细胞核(包括核膜)中的分布和密度在这些细胞类型之间有所不同。然而,这些细胞类型中 ET-1 和 ET(B) 受体的定位和密度相似。细胞外 ET-1 诱导的细胞质 (Ca) 和核内 (Ca) 游离 Ca(2+) 增加与细胞质和核内活性氧的增加有关。细胞外 ET-1 诱导的 Ca 和 Ca 增加以及细胞内 ET-1 诱导的 Ca 增加均依赖于细胞类型。介导细胞外 ET-1 诱导的 Ca 和 Ca 增加的 ET-1 受体类型取决于细胞类型。然而,细胞质 ET-1 诱导的 Ca 增加不依赖于细胞类型。总之,核膜上的 ET-1 受体可能在 ET-1 的整体作用中发挥重要作用。这些核膜 ET-1 受体可能成为新一代拮抗剂的靶点。